NCT03568435View on ClinicalTrials.gov

Safety and Effectiveness of Nivolumab in Recurring Kidney Cancer Participants

CompletedOBSERVATIONAL
Enrollment

212

Participants

Timeline

Start Date

February 14, 2018

Primary Completion Date

December 21, 2020

Study Completion Date

December 21, 2020

Conditions
Kidney CancerRenal Cancer
Interventions
OTHER

Non-Interventional

Non-Interventional

Trial Locations (1)

1070052

Local Institution - 0001, Tokyo

Sponsors

Collaborators (1)

Ono Pharma USA Inc
All Listed Sponsors
collaborator

Ono Pharma USA Inc

INDUSTRY

lead

Bristol-Myers Squibb

INDUSTRY

NCT03568435 - Safety and Effectiveness of Nivolumab in Recurring Kidney Cancer Participants | Biotech Hunter | Biotech Hunter